TargetMol

PACAP (1-38), human, ovine, rat

Product Code:
 
TAR-TP1878
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-TP1878-1mg1mg£188.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TP1878-5mg5mg£422.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
PACAP 1-38 is a neuropeptide with 38 amino acid residues.
CAS:
137061-48-4
Formula:
C203H331N63O53S
Molecular Weight:
4534.26
Purity:
0.98
SMILES:
0

References

Gourlet P, et al. Fragments of pituitary adenylate cyclase activating polypeptide discriminate between type I and II recombinant receptors. Eur J Pharmacol. 1995 Dec 4;287(1):7-11. Gourlet P , Andr? Vandermeers, Vandermeers-Piret M C , et al. Fragments of pituitary adenylate cyclase activating polypeptide discriminate between type I and II recombinant receptors[J]. European Journal of Pharmacology, 1995, 287(1):0-11. Akira Arimura, Min Li, Vecihi Batuman.Potential Protective Action of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP38) on in Vitro and in Vivo Models of Myeloma Kidney Injury .2006 Jan 15;107(2):661-8.